Your genes are one factor among manyincluding dose, individual tolerance, hydration status, and overall healththat shape your experience on treatment
Whether the GIC addresses the issue of GLP-1s for January 1 or at the start of FY27 on July 1, 2026, the Commission will be forced to confront a difficult and controversial issue
Heres what Debbie L
Patients should be informed that gastrointestinal symptoms are dose dependent, common during treatment initiation and escalation, usually transient, influenced by the starting dose, and speed of titration ( Adjunctive dietary and behavioral measures may aid during treatment initiation and dose escalation
Gu F, Chauhan V, Kaur K, Brown WT, LaFauci G, Wegiel J, et al
Diabetes 73 (Suppl